← Back to Vivanza Biosciences Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

VIVANZAPharmaceuticals

Vivanza Biosciences Ltd — Financial Ratios & Key Metrics

₹1.76

+0.00%

P/E RatioN/AxIndustry: 31.77x

ROE-15.58%Return on equity

ROCE-2.77%Return on capital

Debt/Equity2.20High debt

💎

Valuation & Profitability

P/E Ratio

N/Ax

Industry Average P/E

31.77x

Dividend Yield

0.00%

Market Cap

₹8.80 (Cr)

Sales Growth 5Y

-5.02%

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

1.94%

📉

Price Returns

1 Month

+12.24%

3 Months

+7.32%

6 Months

-8.71%

1 Year

-41.95%

52W Low

₹2

Current

₹2

52W High

₹3

-5% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹2

▼ Price below SMA 50 — Bearish

SMA 200

₹2

▼ Long-term downtrend

Volume Signal

110% of avg

Average volume

Technical indicators are for educational purposes only. Not investment advice.

More on Vivanza Biosciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.